Arvin K. George, MD, presented “In-Office Water Vapor Ablation” during the 2022 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on September 23, 2022, in Los Angeles, California.
How to cite: George, Arvin K. “In-Office Water Vapor Ablation.” September 23, 2022. Accessed Jul 2024. https://grandroundsinurology.com/in-office-water-vapor-ablation/
In-Office Water Vapor Ablation – Summary
Arvin K. George, MD, Assistant Professor of Urology at the University of Michigan in Midland, Michigan, provides insights into the Rezum procedure, an in-office treatment for symptomatic benign prostatic hyperplasia (BPH). Using radio frequency power, the procedure generates vapor through an inductive heating coil, resulting in convective vapor ablation. Dr. George explores the indications for Rezum, which includes symptomatic BPH in men above 50 years with gland volumes of 30 to 80 ccs. However, expanding indications for larger glands have shown promising outcomes. He highlights the reduction in IPSS score, improvement in quality of life, and preservation of sexual function observed in clinical studies. While emphasizing the advantages of the procedure, such as its convenience, minimal learning curve, and low retreatment rate, Dr. George also discusses the limitations, including the need for additional data on larger glands and the requirement of a catheter. Overall, the Rezum procedure provides a viable office-based option with satisfactory results for many patients with symptomatic BPH.
The annual symposium on Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies. For more educational activities from the symposium that took place from September 23-24, 2022 in Los Angeles, California, visit our collection page.
ABOUT THE AUTHOR
Arvin George, MD, serves as Director of Prostate Cancer Programs and Associate Professor (PAR) of Urology at Johns Hopkins School of Medicine in Baltimore, Maryland. He is a urologic surgeon who specializes in the diagnosis and management of genitourinary cancers. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his urology residency at the Smith Institute for Urology at the Hofstra North Shore-LIJ School of Medicine. He remained there to complete his endourology fellowship in New York, gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a urologic oncology fellowship at the National Cancer Institute of the National Institutes of Health. Dr. George’s research interests include minimally-invasive and image-guided treatments, functional prostate imaging, and focal therapy for prostate cancer. His research aims to identify appropriate use for imaging in diagnosis, risk stratification, and management of prostate cancer, including active surveillance and selection/treatment of patients with novel focal therapy modalities.
